Kristiina MD Vuori
CIK 1612627 · last filed 2026-09-18
Kristiina MD Vuori is a corporate insider who has filed 38 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for INBX, was dated Sep 18, 2026. Across all open-market trades the lifetime net is +$217.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 5 SEC filings were submitted jointly with Inhibrx, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INBX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
111 EIGHTH AVENUE
NEW YORK, NY 10011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INBX | Director | 20,443 | $89.83 | $1.84M | $300.0K | 9 | 2026-09-18 |
| Forian Inc. (FORA) Delisted | Director | 0 | $2.17 | $0 | $0 | 6 | 2026-05-15 |
| BNGO | Director | — | $1.25 | — | $0 | 3 | 2026-05-14 |
| Inhibrx, Inc. (INBXV) Delisted | Director | — | — | — | $0 | 1 | 2024-05-30 |
| Bionano Genomics, Inc. (BNGOW) Delisted | Director | — | $0.00 | — | $0 | 7 | 2023-06-16 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Director | — | $0.48 | — | $0 | 1 | 2021-04-19 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Director | — | — | — | $0 | 1 | 2020-10-07 |
| WebMD Health Corp. (WBMD) Delisted | Director | 0 | — | — | -$82.8K | 9 | 2017-09-15 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | INBX | Grant (A) | — | $0 | EDGAR |
| 2026-06-04 | INBX | Grant (A) | — | $0 | EDGAR |
| 2026-05-15 | Forian Inc. (FORA) Delisted | Mixed | −28,757 | $0 | EDGAR |
| 2026-05-14 | BNGO | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | BNGO | Grant (A) | — | $0 | EDGAR |
| 2025-05-29 | INBX | Grant (A) | — | $0 | EDGAR |
| 2025-03-28 | Forian Inc. (FORA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-10-07 | INBX | Buy (P) | +6,667 | $100.0K | EDGAR |
| 2024-09-12 | INBX | Buy (P) | +6,636 | $100.0K | EDGAR |
| 2024-09-03 | INBX | Buy (P) | +7,140 | $100.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.